Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Peripheral Blood Stem Cells

Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant

Bone Marrow Transplantation volume 25, pages 589–598 (2000)Cite this article

Abstract

Leukapheresis collections obtained following one of four mobilization regimens from 90 cancer patients were analyzed for their content of various progenitor cell types including erythroid and granulopoietic colony-forming cells in methylcellulose (total CFC), CFC-megakaryocyte (CFC-Mk), CFC detected after 10, 35 and 56 days in long-term culture (LTC), and total CD34+ cells. The number of each of these progenitor cell types collected from individual patients varied over 1000-fold. Nevertheless, within an individual leukapheresis, there was a significant correlation between the number of CD34+ cells and each progenitor type (except day 56 LTC CFC) suggesting that all of them are mobilized by a common mechanism. Patients who had previously received extensive chemotherapy and/or radiotherapy mobilized fewer of all these cell types than those who had not. For the 65 patients who proceeded to autologous transplantation, the median times to an absolute neutrophil count (ANC) of ⩾0.5 × 109/l and the last platelet transfusion post transplant were 13 and 11 days, respectively, with 14 (22%) of patients having platelet recovery delayed beyond day 21. There was no significant difference between patients who had or had not received extensive chemo/radiotherapy or among the different mobilization regimens for time to neutrophil or platelet recovery or the number of platelet or red blood cell transfusions received post transplant. Threshold doses of the different cell types transplanted (per kg of patient weight) which predicted rapid platelet recovery were 2 × 106 CD34+ cells, 5 × 105 total CFC and 2.5 × 104CFC-Mk. Corresponding thresholds for progenitor activity measured in LTC could not be established. These results further support the view that standard mobilization regimens yield progenitor numbers that are, in most cases, nonlimiting for generating neutrophil and platelet recoveries within 2 to 3 weeks after myeloablative therapy. Assessment of the CD34+ cell and/or CFC content of leukapheresis collections may identify patients in whom platelet recovery is likely to be significantly delayed although CFC-Mk enumeration does not appear to offer any unique predictive advantage. Bone Marrow Transplantation (2000) 25, 589–598.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Sheridan WP, Begley CG, Juttner CA et al. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy Lancet 1992 339: 640–644

    Article  CAS  Google Scholar 

  2. Juttner CA, To LB, Ho JQK et al. Early lympho-hemopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia Transplant Proc 1988 20: 40–43

    CAS  PubMed  Google Scholar 

  3. Korbling M, Fliedner TM, Holle R et al. Autologous blood stem cell (ABSCT) vs purged bone marrow transplantation (pABMT) in standard risk AML: Influence of source and cell composition of the autograft on hemopoietic cell survival Bone Marrow Transplant 1991 7: 343–349

    CAS  PubMed  Google Scholar 

  4. Gianni AM, Siena S, Bregni M et al. Granulocyte–macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation Lancet 1989 2: 580–584

    Article  CAS  Google Scholar 

  5. Socinski MA, Cannistra SA, Elias A et al. Granulocyte–macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man Lancet 1988 1: 1194–1198

    Article  CAS  Google Scholar 

  6. Sutherland HJ, Eaves CJ, Lansdorp PM et al. Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants Blood 1994 83: 3808–3814

    CAS  PubMed  Google Scholar 

  7. Chao NJ, Schriber JR, Grimes K et al. Granulocyte colony-stimulating factor ‘mobilized’ peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy Blood 1993 81: 2031–2035

    CAS  PubMed  Google Scholar 

  8. Bishop MR, Anderson JR, Jackson JD et al. High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte–macrophage colony-stimulating factor on the autografts Blood 1994 83: 610–616

    CAS  PubMed  Google Scholar 

  9. Briddell RA, Hartley CA, Smith KA, McNiece IK . Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential Blood 1993 82: 1720–1723

    CAS  PubMed  Google Scholar 

  10. Brugger W, Bross K, Frisch J et al. Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte–macrophage colony-stimulating factor following polychemotherapy with cisplatin Blood 1992 79: 1193–1200

    CAS  PubMed  Google Scholar 

  11. Siena S, Bregni M, Bonsi L et al. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors Exp Hematol 1993 21: 1583–1590

    CAS  PubMed  Google Scholar 

  12. Begley CG, Basser R, Mansfield R et al. Enhanced levels and enhanced clonogenic capacity of blood progenitor cells following administration of stem cell factor plus granulocyte colony-stimulating factor to humans Blood 1997 90: 3378–3389

    CAS  PubMed  Google Scholar 

  13. Lie AKW, Rawling TP, Bayly JL, To LB . Progenitor cell yield in sequential blood stem cell mobilization in the same patients: insights into chemotherapy dose escalation and combination of haemopoietic growth factor and chemotherapy Br J Haematol 1996 95: 39–44

    Article  CAS  Google Scholar 

  14. Siena S, Bregni M, Brando B et al. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte–macrophage colony-stimulating factor Blood 1989 74: 1905–1914

    CAS  PubMed  Google Scholar 

  15. Tanaka R, Matsudaira T, Aizawa J et al. Characterization of peripheral blood progenitor cells (PBPC) mobilized by filgrastim (rHuG-CSF) in normal volunteers: dose–effect relationship for filgrastim with the character of mobilized PBPC Br J Haematol 1996 92: 795–803

    Article  CAS  Google Scholar 

  16. Drake M, Ranaghan L, Morris TCM et al. Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system Br J Haematol 1997 98: 745–749

    Article  CAS  Google Scholar 

  17. Neben S, Hemman S, Montgomery M et al. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents Exp Hematol 1993 21: 156–162

    CAS  PubMed  Google Scholar 

  18. Haas R, Mohle R, Fruhauf S et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma Blood 1994 83: 3787–3794

    CAS  PubMed  Google Scholar 

  19. Hogge D, Fanning S, Bockhold K et al. Quantitation and characterization of human megakaryocyte colony-forming cells using a standardized serum-free agarose assay Br J Haematol 1997 96: 790–800

    Article  CAS  Google Scholar 

  20. Sutherland HJ, Lansdorp PM, Henkelman DH et al. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers Proc Natl Acad Sci USA 1990 87: 3584–3588

    Article  CAS  Google Scholar 

  21. Sutherland DR, Keating A, Nayar R et al. Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry Exp Hematol 1994 22: 1003–1010

    CAS  PubMed  Google Scholar 

  22. Prince HM, Imrie K, Keating A et al. The influence of prior alkylating agent therapy on the collection of peripheral blood progenitor cells in multiple myeloma Exp Hematol 1995 23: 755 (Abstr.)

    Google Scholar 

  23. Morton J, Morton A, Bird R et al. Predictors for optimal mobilization and subsequent engraftment of peripheral blood progenitor cells following intermediate dose cyclophosphamide and G-CSF Leukemia Res 1997 21: 21–27

    Article  CAS  Google Scholar 

  24. Reece DE, Barnett MJ, Shepherd JD et al. High-dose cyclophosphamide, BCNU, and VP16–213 with or without cisplatin (CBV±P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy Blood 1995 86: 451–456

    CAS  PubMed  Google Scholar 

  25. Phillips GL, Shepherd JD, Barnett MJ et al. Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy J Clin Oncol 1991 9: 1880–1888

    Article  CAS  Google Scholar 

  26. Shepherd JD, Barnett MJ, Connors JM et al. Allogeneic bone marrow transplantation for poor-prognosis non-Hodgkin's lymphoma Bone Marrow Transplant 1993 12: 591–596

    CAS  PubMed  Google Scholar 

  27. Hogge DE, Lee CY, Benny WB, Sutherland HJ . Collection of peripheral blood mononuclear cells as a byproduct of platelet pheresis with two different blood cell separators J Clin Apheresis 1992 7: 208–212

    Article  CAS  Google Scholar 

  28. Coulombel L, Eaves AC, Eaves CJ . Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer Blood 1983 62: 291–297

    CAS  PubMed  Google Scholar 

  29. Hogge DE, Lansdorp PM, Reid D et al. Enhanced detection, maintenance and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human Steel factor, interleukin-3 and granulocyte colony-stimulating factor Blood 1996 88: 3765–3773

    CAS  PubMed  Google Scholar 

  30. Eaves CJ, Cashman JD, Eaves AC . Methodology of long-term culture of human hemopoietic cells J Tissue Cult Meth 1991 13: 55–62

    Article  Google Scholar 

  31. Udomsakdi C, Lansdorp PM, Hogge DE et al. Characterization of primitive hematopoietic cells in normal human peripheral blood Blood 1992 80: 2513–2521

    CAS  PubMed  Google Scholar 

  32. Prosper F, Stroncek D, Verfaillie CM . Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor Blood 1996 88: 2033–2042

    CAS  PubMed  Google Scholar 

  33. Hao QL, Thiemann FT, Petersen D et al. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population Blood 1996 88: 3306–3313

    CAS  PubMed  Google Scholar 

  34. Cox DR . Regression models and life tables J R Stat Soc (B) 1972 34: 187–220

    Google Scholar 

  35. Bensinger W, Singer J, Appelbaum F et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor Blood 1993 81: 3158–3163

    CAS  PubMed  Google Scholar 

  36. Dercksen MW, Weimar IS, Richel DJ et al. The value of flow cytometric analysis of platelet glycoprotein expression on CD34+ cells measured under conditions that prevent P-selectin-mediated binding of platelets Blood 1995 86: 3771–3782

    CAS  PubMed  Google Scholar 

  37. Smith C, Gasparetto C, Collins N et al. Purification and partial characterization of a human hematopoietic precursor population Blood 1991 77: 2122–2128

    CAS  PubMed  Google Scholar 

  38. Petzer AL, Hogge DE, Lansdorp PM et al. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium Proc Natl Acad Sci USA 1996 93: 1470–1474

    Article  CAS  Google Scholar 

  39. Conneally E, Cashman J, Petzer A, Eaves C . Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice Proc Natl Acad Sci USA 1997 94: 9836–9841

    Article  CAS  Google Scholar 

  40. Gianni AM, Siena S, Bregni M et al. Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7g/m+) cyclophosphamide cancer therapy Ann Oncol 1993 4: 759–766

    Article  CAS  Google Scholar 

  41. Kotasek D, Shepherd KM, Sage RE et al. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors Bone Marrow Transplant 1992 9: 11–17

    CAS  PubMed  Google Scholar 

  42. Chatta GS, Price TH, Allen RC, Dale DC . Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers Blood 1994 84: 2923–2929

    CAS  PubMed  Google Scholar 

  43. Tong J, Hoffman R, Siena S et al. Characterization and quantitation of primitive hematopoietic progenitor cells present in peripheral blood autografts Exp Hematol 1994 22: 1016–1024

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Cangene, Novartis and StemCell for gifts of reagents, members of the Stem Cell Assay Service and Cryogenic Laboratory of the British Columbia Cancer Agency and the Cell Separator Unit of the Vancouver General Hospital for technical support, Alan Le for help with statistical analysis, and Christine Kelly for typing the manuscript. This work was supported by grants from the British Columbia Health Research Foundation and the National Cancer Institute of Canada (NCIC) with funds from the Terry Fox Run. CJ Eaves is a Terry Fox Cancer Research Scientist of the NCIC.

Author information

Authors and Affiliations

  1. Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, Canada

    DE Hogge, K Lambie, HJ Sutherland, C Currie, MJ Barnett, AC Eaves & CJ Eaves

  2. Division of Hematology, Vancouver General Hospital, Vancouver, Canada

    DE Hogge, HJ Sutherland, WB Benny, C Currie, MJ Barnett & AC Eaves

  3. Division of Hematopathology, Vancouver General Hospital, Vancouver, Canada

    B Dalal

  4. Department of Medicine, University of British Columbia, Vancouver, Canada

    DE Hogge, HJ Sutherland, WB Benny, MJ Barnett & AC Eaves

  5. Department of Pathology, University of British Columbia, Vancouver, Canada

    B Dalal

  6. Department of Medical Genetics, University of British Columbia, Vancouver, Canada

    CJ Eaves

Authors
  1. DE Hogge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Lambie
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. HJ Sutherland
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. WB Benny
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B Dalal
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C Currie
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. MJ Barnett
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. AC Eaves
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. CJ Eaves
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hogge, D., Lambie, K., Sutherland, H. et al. Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant. Bone Marrow Transplant 25, 589–598 (2000). https://doi.org/10.1038/sj.bmt.1702211

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702211

Keywords

This article is cited by

Search

Advanced search

Quick links